Clinical trial AMG420 -20160370
A Phase 1b/2 Multicenter, Open-label, Expansion Study to Assess the Safety and Efficacy of AMG 420 as Monotherapy in Subjects With Relapsed and/or Refractory Multiple Myeloma
| Trial status | Trial closed for recruitment |
|---|---|
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Amgen |
| EudraCT Identifier | 2018-002879-17 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03836053 |
| Last update |